Cortés RJM, Cortés TJMJ, Cortés TRA, Reyes MBJ, Salazar SA, Carrillo ASI, Veyna FN, Luna PF, Aguayo PJ, Macías ILC

Language: Spanish
References: 12
Page: 144-146
PDF size: 350.97 Kb.

ABSTRACT

The atrioventricular block is a delay or interruption of the electrical impulse from the sinusal node, to level of the auriculoventricular nodule is a congenital (BAVC), in one of every 20,000-25,000 born alive. Secondary to an abnormal embryonic development of the node AV, associated with structural cardiac abnormalities or for maternal is immunization with antibodies that cause immunological irreversible damage in the fetal heart tissue, by inflammation and subsequent fibrosis. The factors of worst prognosis are: Coexistence with cardiovascular malformations, heart failure, ventricular frequency below 50 per minute, bradycardia less than 30 per minute during sleep, pacemaker under or changing, long QT. In asymptomatic patient, it is recommended monitoring and follow-up with echocardiography. Indications for permanent pacemaker are: escape rhythm with wide complex, ectopy and ventricular dysfunction, long QT, cardiomegaly and right atrial dilatation.

REFERENCES

1. Michaëlsson M. Congenital heart block: an international study of the natural history. Cardiovasc Clin. 1972; 4: 85-101.

2. Yater WM. Congenital heart block. Review of the literature: report of a case with incomplete heterotaxy, the electrocardiogram in dextrocardia. Am J Dis Child. 1929; 38: 112-136.

3. Grolleau R, Leclerg F, Guillaumont S, Voisin M. Congenital atrioventricular block. Arch Mal Coeur Vaiss. 1999; 92: 47-55.

4. Bradyarrhythmias. In: Nelson: Textbook of pediatrics. WB Saunders, Philadelphia, 1992: 1197.

5. Chuaqui B, Farrú O. Bloqueo atrioventricular completo con doble interrupción del sistema conductor. Rev Chil Pediatr. 1986; 57: 440-444.

6. Bradiarritmias. En: Nelson: Tratado de pediatría. La Habana: Editorial Ciencias Médicas, 1998; 1680.

7. Sirén MK, Julkunen H, Kaaja R, Kurki P, Koskimies S. Role of HLA in congenital heart block: susceptibility alleles in mothers. Lupus. 1999; 8: 52-59.

8. Finkelstein Y, Alder Y, Harel L, Nussinovitch M, Youinou P. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block. Ann Intern Med. 1997; 148: 205-208.

9. Azuafa A, Saulny de Jorgez J, Berroteran O, Moeante A, Abbruzzese C, González C et al. Diagnóstico ecográfico prenatal de bloqueo auriculoventricular congénito. Rev Obstet Ginecol Venez. 1986; 46: 145-146.

10. de Parseval N, Forrest G, Venables PJ, Heidmann T. ERV-3 envelope expression and congenital heart block: what does a physicological knockout teach us. Autoimmunity. 1999; 30: 81-83.

11. Fernández GB, Batista N, Zarlenga B, Román MI, Kreutzer EA. Bloqueo auriculoventricular completo congénito. Rev Lat Cardiol Cir Cardiovasc Infant. 1985; 1: 49-56.

12. Tanel R, Rhodes L. Arritmias en fetos y neonatos. Clínicas de Perinatología. Enfermedades Cardiovasculares en el Neonato. 2001; 1: 181-199.